Adlyxin Approved for Type 2 Diabetes

THURSDAY, July 28, 2016 — Adlyxin (lixisenatide) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release.
As the FDA explained, Adlyxin is a “glucagon-like peptide-1…
Source: Topamax